A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer

Radiotherapy and Oncology

Volumn 43, Issue 1, 1997, Pages 39-46

  Jackson, Stewart M ^a   Weir, Lorna M ^a   Hay, John H ^a   Tsang, Victor H Y ^a   Scott Durham, J ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

accelerated; cancer; head and neck; radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0030945352     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)01944-0     Document Type: Article

References (30)

1. Barton, M.B., Keane, T.J., Gadella, T. and Maki, E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother. Oncol. 23: 137-143, 1992.
2. Bataini, J.P., Ennuyer, A., Poncet, P. and Ghossein, N.A. Treatment of supraglottic cancer by radical high dose radiotherapy. Cancer 33: 1253-1262, 1974.
3. Begg, A.C., Hofland, I., van Glabbeke, M., Bartelink, H. and Horiot, J.C. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: results from the EORTC Cooperative Trial 22851. Semin. Radiat. Oncol. 2: 22-25, 1992.
4. Bourhis, J., Fortin, A., Dupuis, O., Domenge, C., Lusinchi, A., Marandas, P., Schwaab, G., Armend, J.P., Luboinski, B., Malaise, E., Eschwege, F. and Wibault, P. Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas. Int. J. Radial. Oncol. Biol. Phys. 32: 747-752, 1995.
5. Cox, J.D., Pajak, T.F., Marcial, V.A., Coia, L., Mohiuddin, M., Fu, K.K., Selim, H.M., Byhardt, R.W., Rubin, P., Ortiz, H.G. et al. Interruptions adversely affect local control and survival with hyper-fractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313. Cancer 69: 2744-2748, 1992.
6. Cox, J.D., Stetz, J. and Pajak, T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 31: 1341-1346, 1995.
7. Dale, R.G. The application of Ihe linear quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions, and possible implications for treatments involving multiple fractions per day. Br. J. Radiol. 59: 919-927, 1986.
8. Denekamp, J. Changes in the rale of repopulalion during multifraclion irradialion of mouse skin. Br. J. Radiol. 46: 381-387, 1973.
9. Fallai, C., Olmi, P. and Cellai, E. Advanced carcinomas of the oro-pharynx treated wilh radiolherapy - a comparison of three different fractionation schemes. Am. J. Otol. 14: 31-33, 1993.
10. Fowler, J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62: 679-694, 1989.
11. Fowler, J.F. Modelling altered fractionation schedules. Radiation science - of molecules, mice and men. Br. J. Radiol. (Suppl. 24), 187-192, 1992.
12. Fowler, J.F. and Lindstrom, M.J. Loss of local control with prolongation in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 23: 457-467, 1992.
13. Fu, K.K., Clery, M., Ang, K.K., Byhardt, R.W., Maor, M.H. and Beitler, J.J. Randomised phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Int. J. Radiat. Oncol. Biol. Phys. 32: 589-597, 1995.
14. Horiot, J.C., Le Fur, R., N'Guyen, T., Chenal, C., Schraub, S., Alfonsi, S., Gardini, G., van den Bogaert, W., Danczak, S., Bolla, M., van Glabbeke, M. and de Pauw, M. Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trial. Eur. J. Cancer 26: 779-780, 1990.
15. Horiot, J.C., Le Fur, R., N'Guyen, T., Chenal, C., Schraub, S., Alfonsi, S., Gardini, G., van den Bogaert, W., Danczak, S., Bolla, M., van Glabbeke, M. and de Pauw, M. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomised trial of the EORTC cooperative group of radiotherapy. Radiother. Oncol. 25: 231-241, 1992.
16. Horiot, J.C., Begg, A.C., Le Fur, R., Schraub, S., van den Bogaert, W., van Glabbeke, M. and Pierart, M. Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma. Recent Results Cancer Res. 134: 111-119, 1994.
17. Keane, T.J., Fyles, A., O'Sullivan, B., Barton, M., Maki, E. and Simm, J. The effect of treatment duration on local control of squamous carcinoma of the tonsil and carcinoma of the cervix. Semin. Radiat. Oncol. 2: 26-28, 1992.
18. Kummermehr, J., Dorr, W. and Trott, K.R. Kinetics of accelerated repopulation in normal and malignant squamous epithelia during fractionated radiotherapy. Br. J. Radiol. (Suppl. 24), 193-199, 1992.
19. Lamb, D.S., Spry, N.A., Gray, A.J., Johnson, A.D., Alexander, S.R. and Dally, M.J. Accelerated fractionation radiotherapy for advanced head and neck cancer. Radiother. Oncol. 18: 107-116, 1990.
20. Maciejewski, B., Preuss-Bayer, G. and Trott, K.R. The influence of the number of fractions and overall treatment time on the local control of cancer of the larynx. Int. J. Radiat. Oncol. Biol. Phys. 9: 321-328, 1983.
21. Maciejewski, B., Withers, H.R., Taylor, J.M.G. and Hliniak, A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumour dose - response and repopulation. Int. J. Radiat. Oncol. Biol. Phys. 16: 831-843, 1989.
22. Olmi, P., Cellai, E., Chiavacci, A. and Fallia, C. Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequelae. Radiother. Oncol. 17: 199-207, 1990.
23. Pajak, T.F., Laramore, G.E., Marcial, V.A., Fazekas, J.T., Cooper, J., Rubin, P., Curran, W.J. and Davis, L.W. Elapsed treatment days - a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int. J. Radiat. Oncol. Biol. Phys. 20: 13-20, 1991.
24. Paterson, R. The Treatment of Malignant Disease by Radium and XRays. p. 171. Edward Arnold, London, 1948.
25. Pigott, K.H., Dische, S. and Saunders, M.I. The long term outcome after radical radiotherapy for advanced head and neck cancer. Clin. Oncol. 5: 343-349, 1993.
26. Stewart, J.G. and Jackson, A.W. The steepness of the dose response curve both for tumour cure and normal tissue injury. Laryngoscope 7: 1107-1111, 1975.
27. Wang, C.C. Accelerated fractionation: the do's and don'ts. Int. J. Radiat. Oncol. Biol. Phys. 32: 889-890, 1995.
28. Withers, H.R., Thames, H.D. and Peters, L.J. Differences in the fractionation response of acutely and late-responding tissues. In: Progress in Radio-Oncology, Vol II, pp. 287-296. Editors: K.H. Karcher, H.D. Kogelnik and G. Reinartz. Raven Press, New York, 1982.
29. Withers, H.R., Taylor, J.M.G. and Maciejewski, B. The clinical hazard from accelerated tumour growth during radiotherapy. Acta Oncol. 27: 131-146, 1988.
30. Withers, H.R., Peters, L.J., Taylor, J.M.G. et al. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int. J. Radiat. Oncol. Biol. Phys. 33: 563-568, 1995.